Literature DB >> 28869891

Synthesis and biological effect of chrom-4-one derivatives as functional inhibitors of heat shock protein 27.

Soo-Yeon Hwang1, Soo Yeon Kwak2, Youngjoo Kwon1, Yun-Sil Lee3, Younghwa Na4.   

Abstract

Heat Shock Protein 27 (HSP27) is a member of small heat shock proteins with a highly-conserved α-crystalline domain. It inhibits aggregation of damaged proteins through a complex structural systems of phosphorylation-dependent oligomerization and self-assembly. It has been demonstrated that HSP27 is involved in a variety of pathophysiological pathways with negative or positive protective activities. In this study, we synthesized six chromone analogs possessing thiiran-2-ylmethoxy or oxyran-2-ylmethoxy substituents and evaluated their biological activities against HSP27 protein. Compounds YK598-2, J4 and J2 induced significant abnormal HSP27 dimer formation in NCI-H460, a human lung cancer cell line. In synergistic anticancer activity test, the compounds effectively producing abnormal HSP27 cross-linking remarkably enhanced the antiproliferative activity of 17-AAG, a HSP90 inhibitor. Target specificity test using the HSP27-silenced cells (shHSP27) showed that compounds YK598-2, J4, and J2 significantly lost their cross-linking activity only under conditions when HSP27 was deprived of. In the evaluation of cancer cell sensitization with cisplatin, cisplatin-induced lung cancer cell growth inhibition was sensitized with statistical significance by J4 and J2 as compared to compound alone treatment. These results suggest that abnormal HSP27 dimerization can be an efficient control point for cancer cell proliferation and chromone compounds might have potential as anticancer agents that modulate abnormal HSP27 dimerization.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-cancer activity; Chromone analogue; HSP-27 dimerization

Mesh:

Substances:

Year:  2017        PMID: 28869891     DOI: 10.1016/j.ejmech.2017.08.065

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

1.  Heat shock protein 27 activity is linked to endothelial barrier recovery after proinflammatory GPCR-induced disruption.

Authors:  Cara C Rada; Hilda Mejia-Pena; Neil J Grimsey; Isabel Canto Cordova; Joshua Olson; Jacob M Wozniak; David J Gonzalez; Victor Nizet; JoAnn Trejo
Journal:  Sci Signal       Date:  2021-08-31       Impact factor: 8.192

2.  Adverse Effects of High Temperature On Mammary Alveolar Development In Vitro.

Authors:  Haruka Wakasa; Yusaku Tsugami; Taku Koyama; Liang Han; Takanori Nishimura; Naoki Isobe; Ken Kobayashi
Journal:  J Mammary Gland Biol Neoplasia       Date:  2022-05-17       Impact factor: 2.698

3.  The MK2/Hsp27 axis is a major survival mechanism for pancreatic ductal adenocarcinoma under genotoxic stress.

Authors:  Patrick M Grierson; Paarth B Dodhiawala; Yi Cheng; Timothy Hung-Po Chen; Iftikhar Ali Khawar; Qing Wei; Daoxiang Zhang; Lin Li; John Herndon; Joseph B Monahan; Marianna B Ruzinova; Kian-Huat Lim
Journal:  Sci Transl Med       Date:  2021-12-01       Impact factor: 19.319

4.  HSP27 inhibitor attenuates radiation-induced pulmonary inflammation.

Authors:  Jee-Youn Kim; Yong-Min An; Byeong Rok Yoo; Jin-Mo Kim; Song Yee Han; Younghwa Na; Yun-Sil Lee; Jaeho Cho
Journal:  Sci Rep       Date:  2018-03-08       Impact factor: 4.379

5.  Sensitization of lung cancer cells by altered dimerization of HSP27.

Authors:  Byeol Choi; Seul-Ki Choi; You Na Park; Soo-Yeon Kwak; Hwa Jeong Lee; Youngjoo Kwon; Younghwa Na; Yun-Sil Lee
Journal:  Oncotarget       Date:  2017-10-31

Review 6.  Small Hsps as Therapeutic Targets of Cystic Fibrosis Transmembrane Conductance Regulator Protein.

Authors:  Stéphanie Simon; Abdel Aissat; Fanny Degrugillier; Benjamin Simonneau; Pascale Fanen; André-Patrick Arrigo
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

7.  Specific Roles of HSP27 S15 Phosphorylation Augmenting the Nuclear Function of HER2 to Promote Trastuzumab Resistance.

Authors:  Soo-Yeon Hwang; Seul-Ki Choi; Seung Hee Seo; Hyunji Jo; Jae-Ho Shin; Younghwa Na; Yun-Sil Lee; Youngjoo Kwon
Journal:  Cancers (Basel)       Date:  2020-06-11       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.